Somatic mutations and CRISPR/Cas9 library screening integrated analysis identifies cervical cancer drug-resistant pathways

Clin Transl Med. 2021 Dec;11(12):e632. doi: 10.1002/ctm2.632.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems / genetics*
  • CRISPR-Cas Systems / physiology
  • Early Detection of Cancer / methods
  • Early Detection of Cancer / statistics & numerical data
  • Female
  • Humans
  • Mass Screening / methods
  • Mass Screening / statistics & numerical data
  • Medically Unexplained Symptoms*
  • Odds Ratio
  • Signal Transduction / genetics
  • Signal Transduction / physiology
  • Uterine Cervical Neoplasms / diagnosis*
  • Uterine Cervical Neoplasms / genetics
  • Uterine Cervical Neoplasms / physiopathology